DekaBank Deutsche Girozentrale’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80,500	Closed	-$7K	–	1292
2018 Q4	$7K	Sell	80,500 -18,500	-19%	-$12.1K	﹤0.01%	1171
2018 Q3	$192K	Hold	99,000	–	–	﹤0.01%	1067
2018 Q2	$169K	Hold	99,000	–	–	﹤0.01%	1065
2018 Q1	$175K	Sell	99,000 -2,000	-2%	-$4.22K	﹤0.01%	1006
2017 Q4	$302K	Hold	101,000	–	–	﹤0.01%	899
2017 Q3	$302K	Hold	101,000	–	–	﹤0.01%	905
2017 Q2	$440K	Hold	101,000	–	–	﹤0.01%	853
2017 Q1	$471K	Sell	101,000 -8,500	-8%	-$49.3K	﹤0.01%	745
2016 Q4	$648K	Buy	109,500 +8,500	+8%	+$44.4K	0.01%	619
2016 Q3	$536K	Hold	101,000	–	–	0.01%	651
2016 Q2	$378K	Buy	101,000 +37,500	+59%	+$127K	﹤0.01%	734
2016 Q1	$173K	Buy	63,500 +6,500	+11%	+$23.5K	﹤0.01%	869
2015 Q4	$324K	Buy	57,000 +500	+0.9%	+$3.05K	﹤0.01%	783
2015 Q3	$299K	Buy	56,500 +9,500	+20%	+$73.5K	﹤0.01%	786
2015 Q2	$389K	Buy	47,000 +1,500	+3%	+$7.27K	﹤0.01%	757
2015 Q1	$210K	Sell	45,500 -5,500	-11%	-$17.9K	﹤0.01%	890
2014 Q4	$158K	Sell	51,000 -4,500	-8%	-$13.3K	﹤0.01%	877
2014 Q3	$154K	Buy	55,500 +2,000	+4%	+$7.25K	﹤0.01%	852
2014 Q2	$218K	Sell	53,500 -1,500	-3%	-$6.37K	﹤0.01%	735
2014 Q1	$292K	Buy	55,000 +2,779	+5%	+$15.6K	﹤0.01%	666
2013 Q4	$290K	Buy	52,221 +1,014	+2%	+$4.37K	﹤0.01%	616
2013 Q3	$231K	Buy	+51,207	New	+$230K	﹤0.01%	648

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SGYP Position: Q1 2019 in Review

DekaBank Deutsche Girozentrale sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 80,500 shares — an estimated $7K sold.

DekaBank Deutsche Girozentrale first reported a position in SGYP in Q3 2013 and held it in 22 quarters. The position peaked at $648K in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

DekaBank Deutsche Girozentrale reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 80,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $7K.
DekaBank Deutsche Girozentrale first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 22 quarters.
DekaBank Deutsche Girozentrale's Synergy Pharmaceuticals, Inc Common Stock position peaked at $648K in Q4 2016.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2019, filed 10 May 2019.